Selank vs Semax

Peptide researchers exploring nootropic pathways often encounter both Selank and Semax. These two peptides, while both studied for specific therapeutic applications, operate through fundamentally different mechanisms.

Selank is a synthetic heptapeptide derived from tuftsin, researched primarily for anxiety reduction, immune modulation, cognitive enhancement. Its half-life is short in plasma (minutes); intranasal delivery improves CNS access. Administration is typically via intranasal, subcutaneous.

Semax is a synthetic heptapeptide derived from adrenocorticotropic hormone, studied for cognitive enhancement, neuroprotection, mood support. Its half-life is short (minutes); nasal spray extends local bioavailability. Administration is typically via intranasal, subcutaneous.

Here we compare these two compounds side-by-side so you can determine which might better serve your research protocol — or whether they could work together. [PMID: 25313017]; [PMID: 21493795]; [PMID: 21833148]

Selank operates primarily through Enkephalinase inhibition modulating endogenous opioid peptides; IL-6 and TNF-alpha cytokine modulation affecting neuroinflammation; GABAergic system interaction promoting anxiolytic effects. Its clinical research supports applications in anxiety reduction, immune modulation, cognitive enhancement.

Semax works through BDNF expression enhancement in hippocampus and cortex; TrkB receptor activation promoting neuroplasticity; Modulation of serotonin and dopamine neurotransmitter systems. Its clinical research supports applications in cognitive enhancement, neuroprotection, mood support.

Both Selank and Semax are synthetic peptides studied in clinical, clinical research. They share research interest in cognitive enhancement. Both are administered subcutaneously. Both have published research supporting their mechanisms of action.

The key difference lies in mechanism and half-life. Selank (short in plasma (minutes); intranasal delivery improves CNS access) and Semax (short (minutes); nasal spray extends local bioavailability) have distinct pharmacokinetic profiles. Selank targets anxiety reduction, immune modulation primarily, while Semax focuses more on cognitive enhancement, neuroprotection. Their molecular origins differ significantly: Selank derives from synthetic heptapeptide derived from tuftsin, whereas Semax originates from synthetic heptapeptide derived from adrenocorticotropic hormone.

Choose Selank if your research focuses on anxiety reduction, immune modulation. Its short in plasma (minutes); intranasal delivery improves CNS access half-life shapes its dosing protocol. Its primary mechanisms — Enkephalinase inhibition modulating endogenous opioid peptides; IL-6 and TNF-alpha cytokine modulation affecting neuroinflammation — make it the better fit for anxiety reduction-focused protocols.

Choose Semax if you're studying cognitive enhancement, neuroprotection. Its short (minutes); nasal spray extends local bioavailability half-life means dosing. Its mechanisms — BDNF expression enhancement in hippocampus and cortex; TrkB receptor activation promoting neuroplasticity — are better suited for cognitive enhancement-oriented research.